Madison, WI, United States of America

Jeffrey Jones

This inventor holds 2 USPTO granted patents. Top assignee: University of South Florida. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Jones. Retrieved from https://idiyas.com/inventor/jeffrey-jones-3qgrkye3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Jeffrey Jones in Neurodegenerative Disease Treatment

Introduction

Jeffrey Jones, based in Madison, WI, is a notable inventor known for his significant contributions to the field of neurodegenerative disease treatment. With a focus on innovative materials and methods, he has been instrumental in developing therapeutic compounds that address critical health challenges.

Latest Patents

Jeffrey Jones holds two patents, with his latest invention providing groundbreaking methods for the reduction of protein tau and treatment of neurodegenerative diseases. The invention centers on a myricanol compound, predominantly in the form of (+)-αR,11S-myricanol, which is compared to its counterpart (−)-αS,11R-myricanol. In one embodiment, this compound is isolated and exhibits an enantiomeric excess of approximately 86%. The patent delineates therapeutic compositions and methodologies specifically aimed at neurodegenerative diseases linked to the abnormal accumulation of protein tau. It highlights the therapeutic uses of myricanol and myricanone viable for treatment, which are isolated from root barks of various plant species. Additionally, the patent outlines methods for preparing extracts, showcasing a comprehensive approach to tackling these debilitating conditions.

Career Highlights

Currently, Jeffrey Jones collaborates with the University of South Florida, which has fostered an environment for his innovative research and development. His role at this esteemed institution has allowed him to engage in groundbreaking work that merges theoretical understanding with practical applications in medicine.

Collaborations

Throughout his career, Jeffrey has worked closely with colleagues such as Chad Dickey and Matthew Lebar. These collaborations have enriched his work and have been pivotal in advancing research initiatives focused on neurodegenerative conditions.

Conclusion

Jeffrey Jones's innovative contributions to neurodegenerative disease treatment mark him as a significant figure in medical research. His patents reflect a deep commitment to improving health outcomes and signify a proactive approach to one of the most pressing challenges in medical science today. His ongoing work at the University of South Florida and collaborations highlight the importance of teamwork in advancing innovations that can potentially change lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…